Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Kangmei Pharmaceutical Co., Ltd.
  6. Summary
    600518   CNE0000017M1

KANGMEI PHARMACEUTICAL CO., LTD.

(600518)
  Report
 SummaryChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
06/11/2021 06/15/2021 06/16/2021 06/17/2021 06/18/2021 Date
3.1 3.18 3.04 3.06 3.06 Last
53842900 80834170 61383700 33742950 40636660 Volume
+5.08% +2.58% -4.40% +0.66% 0.00% Change
Financials
Sales 2019 11 446 M 1 774 M 1 774 M
Net income 2019 -4 661 M -722 M -722 M
Net Debt 2019 32 427 M 5 025 M 5 025 M
P/E ratio 2019 -3,77x
Yield 2019 -
Sales 2020 5 411 M 839 M 839 M
Net income 2020 -27 736 M -4 298 M -4 298 M
Net Debt 2020 30 513 M 4 729 M 4 729 M
P/E ratio 2020 -0,48x
Yield 2020 -
Capitalization 15 220 M 2 359 M 2 359 M
EV / Sales 2019 4,45x
EV / Sales 2020 8,10x
Nbr of Employees 7 786
Free-Float 55,9%
More Financials
Company
Kangmei Pharmaceutical Co., Ltd is a China-based company, principally engaged in the manufacture and sales of pharmaceutical products. The Company's principal products are Chinese medicines, including American ginseng, notoginseng powder, salvia powder, radix codonopsis pilosulae, maltiflower knotweed, angelica and lonicera flower, among others. The Company is also engaged in the trading of Chinese herbal medicines,... 
Sector
Pharmaceuticals
Calendar
09/01Earnings Release
More about the company
All news about KANGMEI PHARMACEUTICAL CO., LTD.
04/30MARKET CHATTER : Kangmei Pharma Faces Bankruptcy Restructuring Suit; Shares Tank..
MT
04/18MARKET CHATTER : Kangmei Pharma Faces First Class-Action Lawsuit; Shares Slip 5%
MT
04/16KANGMEI PHARMACEUTICALá : China launches first class-action lawsuit in war again..
RE
2020MARKET CHATTER : GF Securities to Rejig Banking Operations After Client's Nearly..
MT
2020KANGMEI PHARMACEUTICALá : Prices of China's Traditional Medicinal Materials Rise..
MT
2020China vows 'zero tolerance' towards illegal market behaviour
RE
2020China's securities watchdog pledges to clean up financial markets
RE
2019China's Kangmei Pharma sinks by daily limit as watchdog accuses it of fraud
RE
2019Chinese firms' missing $6 billion tests regulators' resolve
RE
2019As China pushes traditional medicine globally, illegal wildlife trade flouris..
RE
More news
News in other languages on KANGMEI PHARMACEUTICAL CO., LTD.

- No features available -

More news
Chart KANGMEI PHARMACEUTICAL CO., LTD.
Duration : Period :
Kangmei Pharmaceutical Co., Ltd. Technical Analysis Chart | 600518 | CNE0000017M1 | MarketScreener
Technical analysis trends KANGMEI PHARMACEUTICAL CO., LTD.
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Managers and Directors
NameTitle
Guo Wei Liu General Manager
Jin Cheng Wan Chief Financial Officer & Director
Xing Gu Ma Chairman
Jing Ke Chairman-Supervisory Board
Xu Tang Head-Compliance & Investor Relations
Sector and Competitors
1st jan.Capitalization (M$)
KANGMEI PHARMACEUTICAL CO., LTD.14.18%2 360
JOHNSON & JOHNSON4.98%435 090
ROCHE HOLDING AG12.75%328 768
PFIZER, INC.7.25%220 997
NOVARTIS AG2.73%210 424
ABBVIE INC.7.23%202 939